Ardelyx's Ibsrela sales beat expectations, shares surge

Investing.com -- Shares in biopharmaceutical firm Ardelyx (NASDAQ:ARDX ) experienced a significant rally, surging as much as 15% intraday, marking the most substantial increase since May 3.

The rally followed the company's announcement of preliminary fourth-quarter and full-year revenue for Ibsrela, its treatment for irritable bowel syndrome with constipation.

The revenue figures reported by Ardelyx exceeded the average analyst estimates. The company revealed that its fourth-quarter US net product sales revenue for Ibsrela reached $54 million, surpassing the Bloomberg consensus estimate of $45.4 million.

Looking ahead, Ardelyx anticipates its full-year 2025 US net product sales revenue for Ibsrela to land between $240 million and $250 million.

This projection stands above the estimated figure of $229.6 million. The company's optimistic outlook for Ibsrela's sales performance appears to have resonated with investors, as reflected in the stock's performance.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Source: Investing.com

Publicații recente
Oklo target nearly doubled at Wedbush on AI-driven demand for nuclear energy
24.01.2025 - 18:00
Crypto markets lose steam after Trump's first policy move
24.01.2025 - 18:00
Combination of Google's TPU-DeepMind units may be worth $700 bn - DA Davidson
24.01.2025 - 18:00
British American Tobacco, Altria shares rise after menthol ban proposal dropped
24.01.2025 - 18:00
Morocco stocks higher at close of trade; Moroccan All Shares up 0.34%
24.01.2025 - 18:00
Commerzbank says no talks with UniCredit until specific proposal made
24.01.2025 - 18:00
Venture Global aims for $64 billion valuation at debut in test for energy IPOs
24.01.2025 - 18:00
Intuitive Machines stock surges on NASA contract award
24.01.2025 - 18:00
International Paper's $7.2 billion acquisition of DS Smith gets EU approval
24.01.2025 - 18:00
Short-term stock optimism soars among retail investors, AAII survey shows
24.01.2025 - 18:00
Venture Global shares likely to open up to 6% above IPO price
24.01.2025 - 18:00
Intuitive Surgical, American Express Stir Friday's Market Cap Stock Movers
24.01.2025 - 18:00
BMW joins Chinese EV makers in filing EU court challenge to tariffs
24.01.2025 - 18:00
Turkey stocks lower at close of trade; BIST 100 down 0.08%
24.01.2025 - 18:00
Diageo stock jumps on possible Guinness sale
24.01.2025 - 18:00

© Analytic DC. All Rights Reserved.

new
Analiza pieței Cum va afecta raportul NFP de mâine cursul de schimb al dolarului american?